The National Stock Exchange (NSE) has recognised a one-off provision to settle long-running regulatory disputes with the Securities and Exchange Board of India (SEBI), earmarking roughly $148 million (about ₹13 billion) in the September quarter as a settlement fund. The move came alongside quarterly results that showed a material change in profitability and trading volumes, and it marks a key step in resolving cases that have blocked the exchange’s long-delayed IPO.
Traders and investors now face a simple question: will this tidy-up remove the regulatory overhang and make the NSE listing investable?
NSE disclosed that it has filed two separate settlement applications with SEBI and recognised a provision totalling about ₹13.87 billion in its books, described in public filings as the first-ever provision for these regulatory matters. Most media reports round the figure to ₹1,300 crore when reporting quarterly results. The applications relate to legacy cases, including the 2019 unfair access fine along with issues related to co-location and data sharing.
The timing is notable. The regulatory disputes have been the principal reason the exchange’s IPO has been stalled for nearly a decade; recognising a provision signal shows a desire to settle and get rid of a major listing hurdle. Investors should note that this is a secondary resolution step; final acceptance of any settlement rests with SEBI.
The provision is large in absolute terms but quite limited to the exchange’s recent earnings and capital base. Reuters flagged that consolidated net profit in the quarter was reported at around ₹20.98 billion, down from the prior year, reflecting softer volumes and the impact of the settlement charge. That means the settlement provision shaved a meaningful portion off quarterly profit but is unlikely to impair the exchange’s capital adequacy.
Clearing the regulatory docket is a precondition for SEBI to consider the exchange’s public offering. Filing settlement applications and taking a defined charge materially improve the exchange’s stewardship narrative and could speed SEBI’s review, but there are no guarantees. SEBI must still accept settlement terms, and the regulator has broad discretion.
Risk factors investors should weigh:
Regulatory acceptance risk: SEBI could demand higher penalties or reject terms.
Earnings volatility: one-time charges distort near-term profits; assess fee yields and recurring revenue.
Market-structure risk: Policy changes related to derivatives trading or market access rules could impact NSE’s dominant position and profitability.
Practical takeaways for investors:
Check whether the provision is one-off or a recurring charge (NSE describes it as a first-time provision related to settlement applications).
Look at pro forma earnings excluding the charge to judge underlying operating momentum.
Monitor trading volumes: transaction revenues fell in the quarter, and derivatives volumes have weakened in parts of the reporting period; volume trends will determine long-term revenue resilience.
Setting aside roughly ₹1,300 crore is a pragmatic step that removes a visible accounting and regulatory overhang. For investors, the announcement transforms an abstract legal risk into a quantifiable number, easier to model and price. The crucial next steps are SEBI’s response to the settlement applications, the detailed disclosures in any draft prospectus, and whether the exchange can stabilise trading volumes and margins post-provision. If there is clarity, will the market reward it with a smooth IPO, or will legal and execution risks keep prices low?
References
Reuters
Zee Biz
Reuters
Reuters
Financial Express
Reuters
Reuters
Reuters
Business Standard
This article is for informational purposes only and does not constitute financial advice. It is not produced by the desk of the Kotak Securities Research Team, nor is it a report published by the Kotak Securities Research Team. The information presented is compiled from several secondary sources available on the internet and may change over time. Investors should conduct their own research and consult with financial professionals before making any investment decisions. Read the full disclaimer here.
Investments in securities market are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit. The securities are quoted as an example and not as a recommendation. SEBI Registration No-INZ000200137 Member Id NSE-08081; BSE-673; MSE-1024, MCX-56285, NCDEX-1262.